Assessing reproducibility of diffusion-weighted magnetic resonance imaging studies in a murine model of HER2+ breast cancer
- PMID: 24433723
- PMCID: PMC3939718
- DOI: 10.1016/j.mri.2013.10.013
Assessing reproducibility of diffusion-weighted magnetic resonance imaging studies in a murine model of HER2+ breast cancer
Abstract
Background and purpose: The use of diffusion-weighted magnetic resonance imaging (DW-MRI) as a surrogate biomarker of response in preclinical studies is increasing. However, before a biomarker can be reliably employed to assess treatment response, the reproducibility of the technique must be established. There is a paucity of literature that quantifies the reproducibility of DW-MRI in preclinical studies; thus, the purpose of this study was to investigate DW-MRI reproducibility in a murine model of HER2+ breast cancer.
Materials and methods: Test-Retest DW-MRI scans separated by approximately six hours were acquired from eleven athymic female mice with HER2+ xenografts using a pulsed gradient spin echo diffusion-weighted sequence with three b values [150, 500, and 800s/mm(2)]. Reproducibility was assessed for the mean apparent diffusion coefficient (ADC) from tumor and muscle tissue regions.
Results: The threshold to reflect a change in tumor physiology in a cohort of mice is defined by the 95% confidence interval (CI), which was±0.0972×10(-3)mm(2)/s (±11.8%) for mean tumor ADC. The repeatability coefficient defines this threshold for an individual mouse, which was±0.273×10(-3)mm(2)/s. The 95% CI and repeatability coefficient for mean ADC of muscle tissue were±0.0949×10(-3)mm(2)/s (±8.30%) and±0.266×10(-3)mm(2)/s, respectively.
Conclusions: Mean ADC of tumors is reproducible and appropriate for detecting treatment-induced changes on both an individual and mouse cohort basis.
Keywords: Apparent diffusion coefficient; Diffusion-weighted MRI; Mouse; Reproducibility.
Copyright © 2014 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest: T.E.Y. is a consultant for Eli Lilly and Company. No other authors declare any conflicts of interest.
Figures


Similar articles
-
Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.J Magn Reson Imaging. 2019 Sep;50(3):836-846. doi: 10.1002/jmri.26697. Epub 2019 Feb 27. J Magn Reson Imaging. 2019. PMID: 30811717 Free PMC article.
-
Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial.J Magn Reson Imaging. 2019 Jun;49(6):1617-1628. doi: 10.1002/jmri.26539. Epub 2018 Oct 22. J Magn Reson Imaging. 2019. PMID: 30350329 Free PMC article.
-
Diffusion-weighted MRI of breast lesions: a prospective clinical investigation of the quantitative imaging biomarker characteristics of reproducibility, repeatability, and diagnostic accuracy.NMR Biomed. 2016 Oct;29(10):1445-53. doi: 10.1002/nbm.3596. Epub 2016 Aug 24. NMR Biomed. 2016. PMID: 27553252
-
The QIBA Profile for Diffusion-Weighted MRI: Apparent Diffusion Coefficient as a Quantitative Imaging Biomarker.Radiology. 2024 Oct;313(1):e233055. doi: 10.1148/radiol.233055. Radiology. 2024. PMID: 39377680 Free PMC article. Review.
-
Predicting and monitoring cancer treatment response with diffusion-weighted MRI.J Magn Reson Imaging. 2010 Jul;32(1):2-16. doi: 10.1002/jmri.22167. J Magn Reson Imaging. 2010. PMID: 20575076 Free PMC article. Review.
Cited by
-
Mechanically Coupled Reaction-Diffusion Model to Predict Glioma Growth: Methodological Details.Methods Mol Biol. 2018;1711:225-241. doi: 10.1007/978-1-4939-7493-1_11. Methods Mol Biol. 2018. PMID: 29344892 Free PMC article.
-
Quantitative magnetic resonance imaging and tumor forecasting of breast cancer patients in the community setting.Nat Protoc. 2021 Nov;16(11):5309-5338. doi: 10.1038/s41596-021-00617-y. Epub 2021 Sep 22. Nat Protoc. 2021. PMID: 34552262 Free PMC article. Review.
-
Quantitative Magnetization Transfer Imaging of the Breast at 3.0 T: Reproducibility in Healthy Volunteers.Tomography. 2016 Dec;2(4):260-266. doi: 10.18383/j.tom.2016.00142. Tomography. 2016. PMID: 28090588 Free PMC article.
-
Apparent diffusion coefficient is highly reproducible on preclinical imaging systems: Evidence from a seven-center multivendor study.J Magn Reson Imaging. 2015 Dec;42(6):1759-64. doi: 10.1002/jmri.24955. Epub 2015 May 26. J Magn Reson Imaging. 2015. PMID: 26012876 Free PMC article.
-
Towards integration of 64Cu-DOTA-trastuzumab PET-CT and MRI with mathematical modeling to predict response to neoadjuvant therapy in HER2 + breast cancer.Sci Rep. 2020 Nov 25;10(1):20518. doi: 10.1038/s41598-020-77397-0. Sci Rep. 2020. PMID: 33239688 Free PMC article.
References
-
- Guarneri V, Barbieri E, Dieci MV, Piacentini F, Conte P. Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer. Cancer Treat Rev. 2010;36(Suppl 3):S62–S66. - PubMed
-
- Jackson JR, Patrick DR, Dar MM, Huang PS. Targeted anti-mitotic therapies: can we improve on tubulin agents? Nat Rev Cancer. 2007;7(2):107–117. - PubMed
-
- Jensen LR, Garzon B, Heldahl MG, Bathen TF, Lundgren S, Gribbestad IS. Diffusion-weighted and dynamic contrast-enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients. J Magn Reson Imaging. 2011;34(5):1099–1109. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous